A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT05424887 · UNKNOWN
Trial details
- NCT number
- NCT05424887
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.